Dr. Ulka Vaishampayan discussed early and locally advanced prostate cancer, noting 192,000 new U.S. cases yearly. Key biomarkers include PSA, imaging, and genomics. High-risk cases may need surgery, radiation, or hormone therapy. Tools like Decipher and Artera AI aid decisions. Multidisciplinary care is key.